DE69810651T2 - Azetidinonderivate zur behandlung von hcmv entzündungen - Google Patents

Azetidinonderivate zur behandlung von hcmv entzündungen

Info

Publication number
DE69810651T2
DE69810651T2 DE69810651T DE69810651T DE69810651T2 DE 69810651 T2 DE69810651 T2 DE 69810651T2 DE 69810651 T DE69810651 T DE 69810651T DE 69810651 T DE69810651 T DE 69810651T DE 69810651 T2 DE69810651 T2 DE 69810651T2
Authority
DE
Germany
Prior art keywords
compound
formula
pyridinylmethyl
methyl
tbg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69810651T
Other languages
German (de)
English (en)
Other versions
DE69810651D1 (de
Inventor
Robert Deziel
Eric Malenfant
Jeffrey O'meara
W. Ogilvie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim (Canada) Ltd
Original Assignee
Boehringer Ingelheim (Canada) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim (Canada) Ltd filed Critical Boehringer Ingelheim (Canada) Ltd
Publication of DE69810651D1 publication Critical patent/DE69810651D1/de
Application granted granted Critical
Publication of DE69810651T2 publication Critical patent/DE69810651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69810651T 1997-10-07 1998-10-06 Azetidinonderivate zur behandlung von hcmv entzündungen Expired - Lifetime DE69810651T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6155097P 1997-10-07 1997-10-07
PCT/CA1998/000952 WO1999018071A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (2)

Publication Number Publication Date
DE69810651D1 DE69810651D1 (de) 2003-02-13
DE69810651T2 true DE69810651T2 (de) 2003-08-21

Family

ID=22036487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69810651T Expired - Lifetime DE69810651T2 (de) 1997-10-07 1998-10-06 Azetidinonderivate zur behandlung von hcmv entzündungen

Country Status (11)

Country Link
US (1) US6239125B1 (cg-RX-API-DMAC10.html)
EP (1) EP1021404B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001519328A (cg-RX-API-DMAC10.html)
AT (1) ATE230725T1 (cg-RX-API-DMAC10.html)
AU (1) AU9425998A (cg-RX-API-DMAC10.html)
CA (1) CA2301548C (cg-RX-API-DMAC10.html)
DE (1) DE69810651T2 (cg-RX-API-DMAC10.html)
DK (1) DK1021404T3 (cg-RX-API-DMAC10.html)
ES (1) ES2187063T3 (cg-RX-API-DMAC10.html)
PT (1) PT1021404E (cg-RX-API-DMAC10.html)
WO (1) WO1999018071A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
CN102595902B (zh) * 2009-05-12 2015-04-29 阿尔巴尼分子研究公司 7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
DE377549T1 (de) 1989-01-03 1990-11-08 Marcos Y. Southbridge Mass. Kleinerman Fernmessung physikalischer variablen mit faseroptischen systemen.
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) * 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
HUT75660A (en) * 1994-03-23 1997-05-28 Tokyo Tanabe Co Novel remedy for respiratory-tract viral disease
EP0883402A4 (en) * 1996-01-11 1999-08-11 Smithkline Beecham Corp NEW CYCLOALKYL-SUBSTITUTED IMIDAZOLES
CA2241891A1 (en) * 1996-02-21 1997-08-21 Darwin Discovery Limited Quinolones and their therapeutic use
JPH09255547A (ja) * 1996-03-22 1997-09-30 Kao Corp 皮膚外用剤

Also Published As

Publication number Publication date
CA2301548A1 (en) 1999-04-15
EP1021404A1 (en) 2000-07-26
CA2301548C (en) 2005-05-17
DE69810651D1 (de) 2003-02-13
EP1021404B1 (en) 2003-01-08
ATE230725T1 (de) 2003-01-15
AU9425998A (en) 1999-04-27
JP2001519328A (ja) 2001-10-23
DK1021404T3 (da) 2003-03-24
PT1021404E (pt) 2003-04-30
ES2187063T3 (es) 2003-05-16
US6239125B1 (en) 2001-05-29
WO1999018071A1 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
DE69329296T2 (de) Pyrazolopyrimidine als crf antagonisten
CA2978170C (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
DE3781716T2 (de) Mittel zur ortsspezifischen alkylierung.
DE69808326T2 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
DE60025243T2 (de) Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung
CA3036245C (en) Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
KR101105607B1 (ko) 디펩티딜 펩티데이즈-iv(dpp-iv)저해용 신규 화합물, 그것의 제조방법 및 그것을 활성성분으로서 함유하는 약제 조성물
EP2864318B1 (en) 2-aminopyrazine derivatives as csf-1r kinase inhibitors
KR101979050B1 (ko) Nk-1 수용체 관련 질환의 치료를 위한 치환된 4-페닐-피리딘
KR20110002475A (ko) 치환 피리미딘-5-카르복시아미드 281
DE69221003T2 (de) Antibiotische Carbapenemderivate
EP2562157A1 (en) Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
EP1060175A2 (de) Tryptase-inhibitoren
DE69810800T2 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
DE60123827T2 (de) 1-methylcarbapenemderivate
EP1455790B1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
DE60105746T2 (de) 2-(4-Pyridinyl)-Benzofurane zur Verwendung als Metalloprotease-Inhibitoren
EP1021404B1 (en) Azetidinone derivatives for the treatment of hcmv infections
EP0093252B1 (de) Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP1115731A2 (de) Neue pyranosen
EP0693071B1 (de) Neue carbonsäureester von 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren herstellung sowie deren verwendung
EP0278911A1 (de) Bicyclische beta-Lactam-carbonsäuren
DE69328061T2 (de) Antibiotische Carbapenemverbindungen
DE69108728T2 (de) [3H,7H]THIAZOLO[3,4-a]PYRIDINE MIT ANTIASTHMATISCHER UND ENTZÜNDUNGSHEMMENDER WIRKUNG AUF DIE ATMUNGSWEGE.
DE60130684T2 (de) Substituierte pyrrolidine als ccr-3-rezeptorantagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition